Article info

Download PDFPDF
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy

Authors

  1. Correspondence to Dr Océane Landon-Cardinal, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; oceane.landon-cardinal{at}umontreal.ca
View Full Text

Citation

Landon-Cardinal O, Allard-Chamard H, Chapdelaine H, et al
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy

Publication history

  • Received October 26, 2022
  • Accepted December 24, 2022
  • First published January 6, 2023.
Online issue publication 
March 10, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.